Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market - Snapshot

Helicobacter pylori (H. pylori) is a spiral-shaped gram-negative aerobic bacterium that grows in the digestive tract and has a tendency to infect the stomach. Bacteria play a vital role in balancing the stomach ecology. When H. pylori invades and attacks the stomach lining, it causes stomach infections. These infections can lead to peptic ulcers and gastritis. They are also associated with stomach, duodenal, and gastric cancers. These infections are commonly found in both men as well as women. Over 50% of the world’s population is infected by H. pylori. In some countries, the prevalence of H. pylori is higher than 80%, making this infection one of the most common bacterial infections. In 1994, the WHO’s, International Agency for Research on Cancer classified H. pylori as a Class 1 carcinogen. The global Helicobacter pylori (H. pylori) non-invasive testing market was valued at US$ 518.0 Mn in 2017 and is estimated to reach a value of US$ 731.9 Mn by 2026, expanding at a CAGR of 3.99% during the forecast period.

Most people infected with Helicobacter pylori bacteria are unaware that they have been infected as the infection is mostly asymptomatic. Children are more susceptible to H. pylori infections. Patients suffering from peptic ulcers that are caused by H. pylori experience symptoms such as vomiting, abdominal pain, nausea, loss of appetite, and excessive burping. In some cases, peptic ulcers lead to severe complications such as obstruction in the stomach lining, internal bleeding, or perforation. High prevalence rates of H. pylori bacteria are projected to propel the global Helicobacter pylori (H. pylori) non-invasive testing market during the forecast period. Developing countries reflect a higher prevalence percentage of H. pylori. Poor sanitation, lack of potable water supply, poor food hygiene, poor personal hygiene, and overcrowding are some of the key factors attributed to the spread of H. pylori infections. Rise in awareness regarding this infection among the global population is one of the factors propelling the expansion of the helicobacter pylori (H. pylori) non-invasive testing market. However, low diagnosis rates even in high prevalence geographies, asymptomatic nature of the infection, and stringent regulatory norms are expected to hamper the market.

helicobacter pylori non invasive testing market

The global helicobacter pylori (h. pylori) non-invasive testing market can be segmented based on test type, test method, end-user, and region. In terms of test type, the market can be classified into serology test, stool antigen test (SAT), and urea breath test (UBT). The serology test segment is expected to lose market share during the forecast. Although the serology test method is quick, easy, and cost effective compared to other tests, regional agencies such as the American Gastroenterology Association (AGA) and National Health Services (NHS) have updated their guidelines to recommend stopping the use of serology testing for the detection of H. pylori due to its inaccurate nature. The urea breath test segment is estimated to constitute a significant market share by the end of the forecast period owing to the test’s accuracy and growing availability. Based on test method, the market can be categorized into laboratory-based tests and point-of-care tests. The laboratory-based tests segment is expected to hold a dominant share by the end of 2026. In terms of end-user, the market can be classified into hospitals, clinics, and diagnostic laboratories. The diagnostic laboratories segment is anticipated to account for a major market share, followed by the hospitals segment. The rise in number of diagnostic laboratories can be attributed to a large number of tests being carried out in standalone and hospital-affiliated diagnostic laboratories owing to their ability to handle high volume of tests.

In terms of region, the global helicobacter pylori (h. pylori) non-invasive testing market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to lead the global market in the 2018-2026 period. The expansion of the market in the region can be attributed to the presence of key players in the region and swift technological advancements in the field of helicobacter pylori (h. pylori) non-invasive testing. Europe is expected to hold a prominent market share during the forecast period.

Key players operating in the global helicobacter pylori (h. pylori) non-invasive testing market are DiaSorin S.p.A., Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Alere, Thermo Fisher Scientific, Biomerica, Inc., Certest Biotec S.L., Sekisui Diagnostics, CorisBioconcept SPRL, and Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.

Helicobacter Pylori (H. Pylori) Non-invasive Testing Market to Reduce Morbidity of Gastric and Duodenal Diseases

The testing for H. Pylori non-invasive testing has been attracting high clinical demand on the back of the growing morbidity of gastric and duodenal diseases. H. Pylori infection is usually asymptomatic, contributes significantly to peptic ulcer disease and gastric cancer. The first line of treatment usually includes non-invasive tests for diagnosing H. Pylori infection notably serological test, stool antigen research (STR), and urea breath. Particularly, urea breath test (UBT) and stool antigen research (STR) are both popular tests for diagnosing the conditions, and contributes to the expansion of the H. Pylori non-invasive testing market. The need for effectiveness of anti-microbial treatment is also a key aspect driving demand in the H. Pylori non-invasive testing market. Individual tests vary in sensitivity and specificity, and there is a need more studies to understand the efficacy of non-invasive diagnostic tests. This is essential for screening populations, and has thus become a matter of research concern for organizations, both public and private. Advances made in laboratory serological assay are boosting the market. Several meta-analysis have been conducted to understand the growth trajectories in the H. Pylori non-invasive testing market.

However, several limitations exist as to the serological testing. A telling concern is false positive serology tests in patients who have low prevalence. In the times of Covid-19 where the pandemic-led lockdowns have put unprecedented impacts on how industries conduct businesses, the healthcare sector is also seeing new disruptions. This is expected the medical sector to come out with new strategies and frameworks. Most notably, some of the developing nations will be fast to bounce back, also expanding the horizon in the H. Pylori non-invasive testing market. Advances being made in non-invasive diagnostic immunoassay tests wll chart new growth trajectories for patients with the complications of H. Pylori. Also, the research and development activities will see new surge in investments.  

The global Helicobacter pylori (H. pylori) non-invasive testing market has been segmented as follows:

Test Type

  • Serology Test
  • Stool Antigen Test (SAT)
  • Urea Breath Test (UBT)

Test Method

  • Laboratory-based Tests
  • Point-of-Care Tests

End-user

  • Hospitals
  • Clinics
  • Diagnostic Laboratories

Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Israel
    • Rest of Middle East & Africa

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary:Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market 

4. Market Overview
     4.1. Introduction
            4.1.1. Test Definition
            4.1.2. Industry Evolution/Developments
     4.2. Overview
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
     4.4. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market  Analysis and Forecasts, 2016–2026
            4.4.1. New Non-invasive H. Pylori Test launches, by Market Players 
            4.4.2. Epidemiological Assessment of Helicobacter Pylori 
            4.4.3. Key Technological Advancements in Helicobacter Pylori Diagnostic Testing 

5. Market Outlook
     5.1. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Forecast
     5.2. Market Opportunity Map 
     5.3. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Outlook 
     5.4. Porter’s Five Forces Analysis

6. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market  Analysis and Forecasts, by Test Type
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Market Value  Forecast, by Non-invasive Test Type, 2016–2026
            6.3.1. Serology Test
            6.3.2. Stool antigen test (SAT) 
            6.3.3. Urea Breath Test (UBT)
     6.4. Market Attractiveness, by Non-invasive Test Type

7. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market  Analysis and Forecasts, by Test Method 
     7.1. Introduction & Definition
     7.2. Key Findings/Developments
     7.3. Market Value  Forecast, by Test Method, 2016–2026
            7.3.1. Laboratory Based Tests 
            7.3.2. Point-of-Care Tests
     7.4. Market Attractiveness by Test Method 

8. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market  Analysis and Forecasts, by End User 
     8.1. Introduction & Definition
     8.2. Key Findings / Developments
     8.3. Market Value  Forecast, by End User, 2016–2026
            8.3.1. Hospitals
            8.3.2. Clinics
            8.3.3. Diagnostic Laboratories
     8.4. Market Attractiveness, by End User 

9. Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market  Analysis and Forecasts, by Region
     9.1. Key Findings
     9.2. Market Value  Forecast, by Region
            9.2.1. North America 
            9.2.2. Europe 
            9.2.3. Asia Pacific 
            9.2.4. Latin America 
            9.2.5. Middle East & Africa 
     9.3. Market Attractiveness, by Country/Region

10. North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market  Analysis and Forecast
     10.1. Introduction
            10.1.1. Key Findings
     10.2. Market Value  Forecast, by Non-invasive Test Type, 2016–2026
            10.2.1. Serology Test
            10.2.2. Stool antigen test (SAT) 
            10.2.3. Urea Breath Test (UBT)
     10.3. Market Value  Forecast, by Test Method, 2016–2026
            10.3.1. Laboratory Based Tests 
            10.3.2. Point-of-care Tests
     10.4. Market Value  Forecast, by End User, 2016–2026
            10.4.1. Hospitals
            10.4.2. Clinics
            10.4.3. Diagnostic Laboratories
     10.5. Market Value  Forecast, by Country, 2016–2026
            10.5.1. U.S.
            10.5.2. Canada
     10.6. Market Attractiveness Analysis 
            10.6.1. By Non-invasive Test Type
            10.6.2. By Test Method 
            10.6.3. By End User 
            10.6.4. By Country

11. Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market  Analysis and Forecast     
     11.1. Introduction
            11.1.1. Key Findings
     11.2. Market Value  Forecast, by Non-invasive Test Type, 2016–2026
            11.2.1. Serology Test
            11.2.2. Stool antigen test (SAT) 
            11.2.3. Urea Breath Test (UBT)
     11.3. Market Value  Forecast, by Test Method, 2016–2026
            11.3.1. Laboratory Based Tests 
            11.3.2. Point-of-care Tests
     11.4. Market Value  Forecast, by End User, 2016–2026
            11.4.1. Hospitals
            11.4.2. Clinics
            11.4.3. Diagnostic Laboratories
     11.5. Market Value  Forecast, by Country, 2016–2026
            11.5.1. Germany
            11.5.2. U.K.
            11.5.3. France
            11.5.4. Spain
            11.5.5. Italy
            11.5.6. Rest of Europe
     11.6. Market Attractiveness Analysis 
            11.6.1. By Non-invasive Test Type
            11.6.2. By Test Method 
            11.6.3. By End User 
            11.6.4. By Country

12. Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market  Analysis and Forecast
     12.1. Introduction
            12.1.1. Key Findings
     12.2. Market Value  Forecast, by Non-invasive Test Type, 2016–2026
            12.2.1. Serology Test
            12.2.2. Stool antigen test (SAT) 
            12.2.3. Urea Breath Test (UBT)
     12.3. Market Value  Forecast, by Test Method, 2016–2026
            12.3.1. Laboratory Based Tests 
            12.3.2. Point-of-care Tests
     12.4. Market Value  Forecast, by End User, 2016–2026
            12.4.1. Hospitals
            12.4.2. Clinics
            12.4.3. Diagnostic Laboratories
     12.5. Market Value  Forecast, by Country, 2016–2026
            12.5.1. China
            12.5.2. Japan
            12.5.3. India
            12.5.4. Australia & New Zealand
            12.5.5. Rest of Asia Pacific
     12.6. Market Attractiveness Analysis 
            12.6.1. By Non-invasive Test Type
            12.6.2. By Test Method 
            12.6.3. By End User 
            12.6.4. By Country

13. Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market  Analysis and Forecast
     13.1. Introduction
            13.1.1. Key Findings
     13.2. Market Value  Forecast, by Non-invasive Test Type, 2016–2026
            13.2.1. Serology Test
            13.2.2. Stool antigen test (SAT) 
            13.2.3. Urea Breath Test (UBT)
     13.3. Market Value  Forecast, by Test Method, 2016–2026
            13.3.1. Laboratory Based Tests 
            13.3.2. Point-of-Care Tests
     13.4. Market Value  Forecast, by End User, 2016–2026
            13.4.1. Hospitals
            13.4.2. Clinics
            13.4.3. Diagnostic Laboratories
     13.5. Market Value  Forecast by Country, 2016–2026
            13.5.1. Brazil
            13.5.2. Mexico
            13.5.3. Rest of Latin America
     13.6. Market Attractiveness Analysis 
            13.6.1. By Non-invasive Test Type
            13.6.2. By Test Method 
            13.6.3. By End User 
            13.6.4. By Country

14. Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market  Analysis and Forecast
     14.1. Introduction
            14.1.1. Key Findings
     14.2. Market Value  Forecast, by Non-invasive Test Type, 2016–2026
            14.2.1. Serology Test
            14.2.2. Stool antigen test (SAT) 
            14.2.3. Urea Breath Test (UBT)
     14.3. Market Value  Forecast, by Test Method, 2016–2026
            14.3.1. Laboratory Based Tests 
            14.3.2. Point-of-Care Tests
     14.4. Market Value  Forecast, by End User, 2016–2026
            14.4.1. Hospitals
            14.4.2. Clinics
            14.4.3. Diagnostic Laboratories
     14.5. Market Value  Forecast, by Country, 2016–2026
            14.5.1. GCC Countries
            14.5.2. South Africa
            14.5.3. Israel
            14.5.4. Rest of Middle East & Africa
     14.6. Market Attractiveness Analysis 
            14.6.1. By Non-invasive Test Type
            14.6.2. By Test Method 
            14.6.3. By End User 
            14.6.4. By Country

15. Competition Landscape
     15.1. Market Player – Competition Matrix (By Tier and Size of companies)
     15.2. Market Share Analysis, by Company (2017),Estimated
     15.3. Market Footprint Analysis
            15.3.1. By Region
            15.3.2. By Non-invasive Test Type
     15.4. Competitive Business Strategies
     15.5. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)*
            15.5.1. DiaSorin S.p.A.
                      15.5.1.1 Company Overview (HQ, Business Segments, Employee Strengths)
                      15.5.1.2 Financial Overview
                      15.5.1.3 Product Portfolio
                      15.5.1.4 SWOT Analysis
                      15.5.1.5 Strategic Overview
            15.5.2. Meridian Bioscience, Inc.
                      15.5.2.1 Company Overview (HQ, Business Segments, Employee Strengths)
                      15.5.2.2 Financial Overview
                      15.5.2.3 Product Portfolio
                      15.5.2.4 SWOT Analysis
                      15.5.2.5 Strategic Overview
            15.5.3. Exalenz Bioscience Ltd.
                      15.5.3.1 Company Overview (HQ, Business Segments, Employee Strengths)
                      15.5.3.2 Financial Overview
                      15.5.3.3 Product Portfolio
                      15.5.3.4 SWOT Analysis
                      15.5.3.5 Strategic Overview
            15.5.4. Alere
                      15.5.4.1 Company Overview (HQ, Business Segments, Employee Strengths)
                      15.5.4.2 Financial Overview
                      15.5.4.3 Product Portfolio
                      15.5.4.4 SWOT Analysis
                      15.5.4.5 Strategic Overview
            15.5.5. Thermo Fisher Scientific
                      15.5.5.1 Company Overview (HQ, Business Segments, Employee Strengths)
                      15.5.5.2 Financial Overview
                      15.5.5.3 Product Portfolio
                      15.5.5.4 SWOT Analysis
                      15.5.5.5 Strategic Overview
            15.5.6. Biomerica, Inc.
                      15.5.6.1 Company Overview (HQ, Business Segments, Employee Strengths)
                      15.5.6.2 Financial Overview
                      15.5.6.3 Product Portfolio
                      15.5.6.4 SWOT Analysis
                      15.5.6.5 Strategic Overview
            15.5.7. Certest Biotec S.L.
                      15.5.7.1 Company Overview (HQ, Business Segments, Employee Strengths)
                      15.5.7.2 Financial Overview
                      15.5.7.3 Product Portfolio
                      15.5.7.4 SWOT Analysis
                      15.5.7.5 Strategic Overview
            15.5.8. Sekisui Diagnostics
                      15.5.8.1 Company Overview (HQ, Business Segments, Employee Strengths)
                      15.5.8.2 Financial Overview
                      15.5.8.3 Product Portfolio
                      15.5.8.4 SWOT Analysis
                      15.5.8.5 Strategic Overview
            15.5.9. CorisBioconcept SPRL 
                      15.5.9.1 Company Overview (HQ, Business Segments, Employee Strengths)
                      15.5.9.2 Financial Overview
                      15.5.9.3 Product Portfolio
                      15.5.9.4 SWOT Analysis
                      15.5.9.5 Strategic Overview
            15.5.10. Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
                      15.5.10.1 Company Overview (HQ, Business Segments, Employee Strengths)
                      15.5.10.2 Financial Overview
                      15.5.10.3 Product Portfolio
                      15.5.10.4 SWOT Analysis
                      15.5.10.5 Strategic Overview 

*Note: Financial details for companies that do not report this information in public domain might not be captured.

List of Tables

Table 01: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value (US$ Mn) Forecast, by Non-invasive Test Type, 2016–2026
Table 02: Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market Value (US$ Mn) Forecast, by Test Method, 2016–2026
Table 03: Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market Value (US$ Mn) Forecast, by End User, 2016–2026
Table 04: Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 05: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Country, 2016–2026
Table 06: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2016–2026
Table 07: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Test Method, 2016–2026
Table 08: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by End User, 2016–2026
Table 09: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Country, 2016–2026
Table 10: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2016–2026
Table 11: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Test Method, 2016–2026
Table 12: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by End User, 2016–2026
Table 13: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Country, 2016–2026
Table 14: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2016–2026
Table 15: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Test Method, 2016–2026
Table 16: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by End User, 2016–2026
Table 17: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Country, 2016–2026
Table 18: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2016–2026
Table 19: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Test Method, 2016–2026
Table 20: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by End User, 2016–2026
Table 21: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Country, 2016–2026
Table 22: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Non-invasive Test Type, 2016–2026
Table 23: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by Test Method, 2016–2026
Table 24: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) Forecast, by End User, 2016–2026

List of Figures

Figure 01: Prevalence of Helicobacter Pylori, North America, 2016
Figure 02: Prevalence of Helicobacter Pylori, Europe, 2016
Figure 03: Prevalence of Helicobacter Pylori, Asia Pacific, 2016
Figure 04: Prevalence of Helicobacter Pylori, Latin America, 2016
Figure 05: Prevalence of Helicobacter Pylori, Middle East & Africa, 2016
Figure 06: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Size (US$ Mn) Forecast, 2018–2026
Figure 07: Opportunity Map, by Non-invasive Test Type and Test Method, 2017
Figure 08: Opportunity Map, by End User, 2017
Figure 09: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Region (2017)
Figure 10: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Test Method (2017)
Figure 11: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Non-Invasive Test Type (2017)
Figure 12: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by End-user (2017)
Figure 13: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Non-invasive Test Type, 2018 and 2026
Figure 14: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn), by Serology Test, 2016–2026
Figure 15: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn), by SAT, 2016–2026
Figure 16: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by UBT, 2016–2026
Figure 17: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness, by Non-invasive Test Type, 2018–2026
Figure 18: Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market Value Share, by Test Method, 2018 and 2026
Figure 19: Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market Attractiveness, by Test Method, 2018–2026
Figure 20: Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue (US$ Mn), by Laboratory Based Tests, 2016–2026
Figure 21: Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue (US$ Mn), by Point-of-Care Tests, 2016–2026
Figure 22: Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market Value Share, by End User, 2018 and 2026
Figure 23: Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market Attractiveness, by End User, 2018–2026
Figure 24: Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue (US$ Mn), by Hospitals, 2016–2026
Figure 25: Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue (US$ Mn), by Clinics, 2016–2026
Figure 26: Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue (US$ Mn), by Diagnostic Labs, 2016–2026
Figure 27: Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market Value Share (%), by Region, 2018 and 2026
Figure 28: Global Helicobacter Pylori (H. pylori) Non-invasive Testing Market Attractiveness, by Region, 2018–2026
Figure 29: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Country, 2018 and 2026
Figure 30: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness, by Country, 2018–2026
Figure 31: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Non-invasive Test Type, 2018 and 2026
Figure 32: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness, by Non-invasive Test Type, 2018–2026
Figure 33: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Test Method, 2018 and 2026
Figure 34: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness, by Test Method, 2018–2026
Figure 35: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by End User, 2018 and 2026
Figure 36: North America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness, by End User, 2018–2026
Figure 37: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Country, 2018 and 2026
Figure 38: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness, by Country, 2018–2026
Figure 39: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Non-invasive Test Type, 2018 and 2026
Figure 40: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness, by Non-invasive Test Type, 2018–2026
Figure 41: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Test Method, 2018 and 2026
Figure 42: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness, by Test Method, 2018–2026
Figure 43: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by End User, 2018 and 2026
Figure 44: Europe Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness, by End User, 2018–2026
Figure 45: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Country, 2018 and 2026
Figure 46: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness, by Country, 2018–2026
Figure 47: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Non-invasive Test Type, 2018 and 2026
Figure 48: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness, by Non-invasive Test Type, 2018–2026
Figure 49: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Test Method, 2018 and 2026
Figure 50: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness, by Test Method, 2018–2026
Figure 51: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by End User, 2018 and 2026
Figure 52: Asia Pacific Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness, by End User, 2018–2026
Figure 53: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Country, 2018 and 2026
Figure 54: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness, by Country, 2018–2026
Figure 55: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Non-invasive Test Type, 2018 and 2026
Figure 56: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness, by Non-invasive Test Type, 2018–2026
Figure 57: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Test Method, 2018 and 2026
Figure 58: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness, by Test Method, 2018–2026
Figure 59: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by End User, 2018 and 2026
Figure 60: Latin America Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness, by End User, 2018–2026
Figure 61: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Country, 2018 and 2026
Figure 62: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness, by Country, 2018–2026
Figure 63: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Non-invasive Test Type, 2018 and 2026
Figure 64: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness, by Non-invasive Test Type, 2018–2026
Figure 65: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by Test Method, 2018 and 2026
Figure 66: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness, by Test Method, 2018–2026
Figure 67: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Value Share, by End User, 2018 and 2026
Figure 68: Middle East & Africa Helicobacter Pylori (H. Pylori) Non-invasive Testing Market Attractiveness, by End User, 2018–2026
Figure 69: Global Helicobacter Pylori (H. Pylori) Non-invasive Testing, Company Share Analysis, 2017 (Estimated) 
Figure 70: DiaSorin S.p.A Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 71: DiaSorin S.p.A Breakdown of Net Sales (%), by Region, 2017
Figure 72: Meridian Bioscience, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 73: Meridian Bioscience, Inc. Breakdown of Net Sales (%), by Business Segment, 2017
Figure 74: Exalenz Bioscience Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 75: Exalenz Bioscience Ltd. R&D Expenditure (US$ Mn), 2015-2017
Figure 76: Alere (Abbott) Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 77: Alere (Abbott) Breakdown of Net Sales (%), by Business Segment, 2017
Figure 78: Thermo Fisher Scientific Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 79: Thermo Fisher Scientific Breakdown of Net Sales (%), by Business Segment, 2017

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Helicobacter Pylori (H. Pylori) Non-invasive Testing Market